SK179499A3 - The use of insulin sensitiser and alpha-glucosidase inhibitive antihyperglycaemic agent - Google Patents

The use of insulin sensitiser and alpha-glucosidase inhibitive antihyperglycaemic agent Download PDF

Info

Publication number
SK179499A3
SK179499A3 SK1794-99A SK179499A SK179499A3 SK 179499 A3 SK179499 A3 SK 179499A3 SK 179499 A SK179499 A SK 179499A SK 179499 A3 SK179499 A3 SK 179499A3
Authority
SK
Slovakia
Prior art keywords
compound
pharmaceutical composition
comprises administering
dione
benzyl
Prior art date
Application number
SK1794-99A
Other languages
English (en)
Slovak (sk)
Inventor
Robert Gordon Giles
Norman John Lewis
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712865.6A external-priority patent/GB9712865D0/en
Priority claimed from GBGB9806708.5A external-priority patent/GB9806708D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK179499A3 publication Critical patent/SK179499A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)
SK1794-99A 1997-06-18 1998-06-15 The use of insulin sensitiser and alpha-glucosidase inhibitive antihyperglycaemic agent SK179499A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9712865.6A GB9712865D0 (en) 1997-06-18 1997-06-18 Novel method of treatment
GBGB9806708.5A GB9806708D0 (en) 1998-03-27 1998-03-27 Novel method
PCT/EP1998/003691 WO1998057635A1 (en) 1997-06-18 1998-06-15 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor

Publications (1)

Publication Number Publication Date
SK179499A3 true SK179499A3 (en) 2000-11-07

Family

ID=26311746

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1794-99A SK179499A3 (en) 1997-06-18 1998-06-15 The use of insulin sensitiser and alpha-glucosidase inhibitive antihyperglycaemic agent

Country Status (24)

Country Link
EP (1) EP0975343A1 (xx)
JP (1) JP2001523271A (xx)
KR (1) KR20010013845A (xx)
CN (1) CN1274282A (xx)
AP (1) AP9901720A0 (xx)
AR (2) AR014881A1 (xx)
AU (1) AU8799998A (xx)
BG (1) BG103966A (xx)
BR (1) BR9810186A (xx)
CA (1) CA2294134A1 (xx)
CO (1) CO4940453A1 (xx)
DZ (1) DZ2519A1 (xx)
EA (1) EA200000040A1 (xx)
IL (1) IL133138A0 (xx)
MA (1) MA26510A1 (xx)
NO (1) NO996270L (xx)
NZ (1) NZ501345A (xx)
OA (1) OA11631A (xx)
PE (1) PE89199A1 (xx)
PL (1) PL337577A1 (xx)
SK (1) SK179499A3 (xx)
TR (1) TR199903072T2 (xx)
UY (1) UY25051A1 (xx)
WO (1) WO1998057635A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0009934A (pt) 1999-04-23 2002-06-04 Smithkline Beecham Plc Produto farmacêutico
CN100384430C (zh) 2001-04-04 2008-04-30 奥索-麦克尼尔药品公司 含有葡萄糖重吸收抑制剂和维生素a类-x受体调节剂的联合治疗
CA2442917C (en) 2001-04-04 2011-02-01 Ortho-Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
JP2004067575A (ja) * 2002-08-06 2004-03-04 Yaizu Suisankagaku Industry Co Ltd 糖尿病治療薬効果促進剤
CN101121004B (zh) * 2006-08-08 2010-07-21 鲁南制药集团股份有限公司 含有胰岛素增敏剂和米格列醇的药物组合物
CN101584688B (zh) * 2008-05-24 2010-11-10 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物
CN101584705B (zh) * 2008-05-24 2010-10-27 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900435A (en) * 1991-08-26 1999-05-04 Pharmacia & Upjohn Company Composition, food product and uses of 3-guanidinopropionic acid
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
AR013352A1 (es) 2000-12-27
WO1998057635A1 (en) 1998-12-23
AP9901720A0 (en) 1999-12-31
UY25051A1 (es) 2000-09-29
JP2001523271A (ja) 2001-11-20
KR20010013845A (ko) 2001-02-26
AU8799998A (en) 1999-01-04
MA26510A1 (fr) 2004-12-20
TR199903072T2 (xx) 2000-07-21
OA11631A (en) 2004-11-22
AR014881A1 (es) 2001-04-11
PE89199A1 (es) 1999-10-23
IL133138A0 (en) 2001-03-19
BG103966A (bg) 2000-07-31
CO4940453A1 (es) 2000-07-24
PL337577A1 (en) 2000-08-28
EA200000040A1 (ru) 2000-08-28
NO996270D0 (no) 1999-12-17
DZ2519A1 (fr) 2003-02-01
NO996270L (no) 1999-12-17
NZ501345A (en) 2001-10-26
CN1274282A (zh) 2000-11-22
BR9810186A (pt) 2000-08-08
EP0975343A1 (en) 2000-02-02
CA2294134A1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
SK179299A3 (en) Use of insulin sensitiser and a biguanide antihyperglycaemic agent
US20050059706A1 (en) Treatment of diabetes with thiazolidinedione and metformin
SK592000A3 (en) USE OF INSULIN SENSITISER, INSULIN SECRETAGOGUE PROMOTOR ANDì (54) BIGUANIDE ANTIHYPERGLYCAEMIC AGENT FOR THE TREATMENT OF
JP2005247865A (ja) チアゾリジンジオンおよびスルホニル尿素を用いる糖尿病の治療
SK179399A3 (en) Use of insulin sensitiser and an insulin
SK179499A3 (en) The use of insulin sensitiser and alpha-glucosidase inhibitive antihyperglycaemic agent
US20050054687A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
SK286028B6 (sk) Farmaceutický prostriedok a jeho použitie
SK612000A3 (en) Application of insulin sensitiser, insulin secretagogue and alpha glucosidase inhibitor antihyperglycaemic agent for the treatment of diabetes mellitus and conditions associated with diabetes mellitus and a pharmaceutical composition
US20020045649A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
US20030073645A1 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
MXPA99012078A (en) Treatment of diabetes with thiazolidinedione and metformin
SK5322000A3 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
MXPA99012098A (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
NZ520542A (en) Treatment of diabetes with thiazolidinedione and metformin
AU1011902A (en) Treatment of diabetes with thiazolidinedione and metformin
UA68352C2 (en) Method for treatment of diabetes mellitus with thiazolidin and metformin
MXPA00003634A (en) Use of thiazolidinediones for the treatment of hyperglycaemia
CA2549864A1 (en) Treatment of diabetes with thiazolidinedione and metformin